糖尿病管理的工程益生菌:转化微生物学中的进步,挑战和未来方向
Shenghao Zhang1, Jiahui Ma1, Yilei Ma1
1Institute of Life Sciences & Biomedical Collaborative Innovation Center of Zhejiang Province, Wenzhou University, Wenzhou, 325035, People's Republic of China.
International journal of nanomedicine
|November 4, 2024
概括
生物工程益生菌为糖尿病管理提供了一个有希望的替代方案,克服了传统治疗和标准益生菌的局限性. 这些先进的益生菌增强了肠道健康和代谢功能,改善了DM管理.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病是一种全球性健康挑战,发病率不断上升.
- 传统的DM治疗方法往往会产生不良影响.
- 标准益生菌在胃肠道内的稳定性和有效性受到限制.
研究的目的:
- 综合最近对DM管理工程益生菌的研究.
- 阐明这些益生菌的作用机制.
- 评估它们的临床有效性,提高公众意识.
主要方法:
- 对各种益生菌工程方法的审查:物理改变,生物丰富和遗传操纵.
- 分析这些工程益生菌如何影响肠道微生物群,肠道屏障功能,代谢途径和免疫反应.
主要成果:
- 与传统方法相比,工程益生菌显示出增强的治疗功效.
- 这些益生菌有效调节与DM相关的关键生理系统.
- 进步使得工程益生菌成为可信的治疗策略.
结论:
- 工程益生菌代表了糖尿病管理的重大进步.
- 它们为现有治疗方法提供了潜在的优越替代方案.
- 进一步的研究和公众意识对于其临床采用至关重要.
相关概念视频
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
Biological Methods for Microbial Control
2
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
2


